• HOME
  • NEWS
    • BIOENGINEERING
    • SCIENCE NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • FORUM
    • INSTAGRAM
    • TWITTER
  • CONTACT US
Monday, May 23, 2022
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
    • BIOENGINEERING
    • SCIENCE NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • FORUM
    • INSTAGRAM
    • TWITTER
  • CONTACT US
  • HOME
  • NEWS
    • BIOENGINEERING
    • SCIENCE NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • FORUM
    • INSTAGRAM
    • TWITTER
  • CONTACT US
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Health

McLean receives $13.5 million NIMH grant for translational stress research

Bioengineer by Bioengineer
May 14, 2019
in Health
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

The National Institute of Mental Health has awarded a $13.5 million grant to a team of McLean Hospital investigators to support their research into stress chemicals and circuits in the brain

IMAGE

Credit: McLean Hospital

The National Institute of Mental Health (NIMH) has awarded a $13.5 million grant to a team of McLean Hospital investigators to support their research into stress chemicals and circuits in the brain. According to Bill Carlezon, PhD, chief of McLean’s Basic Neuroscience Division and one of the lead researchers, the Silvio O. Conte Center for Translational Mental Health Research at McLean Hospital will investigate “the ways in which stress re-wires the brain and causes persistent changes in sleep and circadian rhythms, and how these changes contribute to psychiatric illnesses such as depression and PTSD (post-traumatic stress disorder).”

Carlezon said the researchers will “treat sleep as a hub for this work because sleep disturbances are especially prominent in stress disorders.” According to McLean’s Chief Scientific Officer Kerry J. Ressler, MD, PhD, another leader of the program, “Stress and anxiety disorders are exceptionally difficult to treat, and symptoms such as sleep disruption often become a source of other debilitating medical conditions.” For example, people with PTSD often have nightmares that keep them awake, and problems with sleep can lead to other serious physical and mental health issues, including those that are caused by the use of drugs and alcohol in attempts to facilitate sleep.

Through the center, researchers will examine “stress peptides,” which are brain chemicals that regulate the body’s responses to stress. The work includes molecular-to-behavioral analyses using animal models, humans, and human brains donated for research. “The center is designed to give us not only new brain targets for medication development, but also a basis for identifying areas that will improve our ability to accurately diagnose these conditions and see when treatments are working,” said Carlezon.

The grant, which is the largest ever received by McLean, will run for five years, allowing McLean to bring together researchers from across the institution who had been working separately on projects related to stress and the brain factors that regulate it. “This grant enables us to come together as a large team and combine our efforts,” said Carlezon. Building on McLean’s long-standing commitment to translational research, the grant creates a formal framework for team members to “be in regular communication and better understand each other’s experiments,” he said. “It makes rapid feedback and dynamic interaction much easier.”

Assisting these efforts will be students from McLean and beyond. “The grant provides us with funds to award our own mini-grants to researchers within the McLean and Harvard systems and to develop programs where we can better support early career investigators,” Carlezon said.

Moreover, the grant facilitates routine interactions between McLean researchers and undergraduates from a network of local colleges with strong neuroscience programs, including Amherst College, Bates College, Bowdoin College, Colby College, and Regis College. Carlezon said that this element of the grant will allow McLean researchers to create a “pipeline for young investigators to become involved in the work while seeding enthusiasm for brain research across New England.”

###

Joining Carlezon and Ressler as leaders on the research team are Elena H. Chartoff, PhD, Vadim Bolshakov, PhD, Edward G. Meloni, PhD, Isabelle M. Rosso, PhD, Scott L. Rauch, MD, and Sabina Berretta, MD.

McLean Hospital has a continuous commitment to put people first in patient care, innovation and discovery, and shared knowledge related to mental health. In 2017 and 2018, it was named the #1 hospital for psychiatric care in the United States by U.S. News & World Report. McLean Hospital is the largest psychiatric affiliate of Harvard Medical School and a member of Partners HealthCare. For more information, please visit mcleanhospital.org or follow us on Facebook or Twitter.

Media Contact
Laura Neves
[email protected]

Original Source

https://www.mcleanhospital.org/news?field_post_type_tid=17

Tags: Depression/AngerMedicine/HealthMental HealthStress/Anxiety
Share13Tweet7Share2ShareShareShare1

Related Posts

Shonta Chambers, MSW

National Comprehensive Cancer Network honors oncology leaders promoting progress in cancer care

May 23, 2022
1 in 10 parents say COVID masking and vaccination essential to summer camp decisions

National Poll: Safety not always top of mind for parents choosing kids’ summer camps

May 23, 2022

Journal of Parkinson’s Disease welcomes new co-Editor-in-Chief Lorraine V. Kalia, MD, PhD, FRCPC

May 20, 2022

Haywire T cells attack protein in “bad” cholesterol

May 20, 2022
Please login to join discussion

POPULAR NEWS

  • Weybourne Atmospheric Observatory

    Breakthrough in estimating fossil fuel CO2 emissions

    46 shares
    Share 18 Tweet 12
  • Hidden benefit: Facemasks may reduce severity of COVID-19 and pressure on health systems, researchers find

    44 shares
    Share 18 Tweet 11
  • Discovery of the one-way superconductor, thought to be impossible

    43 shares
    Share 17 Tweet 11
  • Sweet discovery could drive down inflammation, cancers and viruses

    43 shares
    Share 17 Tweet 11

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Tags

VaccineVaccinesWeather/StormsViolence/CriminalsWeaponryZoology/Veterinary ScienceVirusVehiclesUniversity of WashingtonUrogenital SystemVirologyUrbanization

Recent Posts

  • Custom ‘headphones’ boost atomic radio reception 100-fold
  • New discovery of missing Victorian dinosaurs at world’s first Jurassic Park
  • Protection of sodium metal anodes meets in situ photoelectron spectroscopy
  • A subtle genetic change gives new clues about epilepsy
  • Contact Us

© 2019 Bioengineer.org - Biotechnology news by Science Magazine - Scienmag.

No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

© 2019 Bioengineer.org - Biotechnology news by Science Magazine - Scienmag.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
Posting....